Anti-HIV GP41 [2E7 (L92E7)]
AB02411-23.159-BT
ApplicationsELISA, Neutralisation/Blocking
Product group Antibodies
ReactivityVirus
Targetenv
Overview
- SupplierAbsolute Antibody
- Product NameAnti-HIV GP41 [2E7 (L92E7)]
- Delivery Days Customer9
- Antibody SpecificityThis antibody binds a new linear epitope in the first heptad repeat of gp41 that is only exposed in the fusion-intermediate conformation.
- Application Supplier NoteThis highly potent broadly neutralizing antibody binds HIV-gp41 and is capable of neutralizing HIV strains belonging to the A, A/G, B, B/C and C subtypes. The binding of the antibody to various envelope glycoprotein was confirmed using ELISA (PMID: 22438910). A bispecific VHH with 2E7 and CD4bs VHH (J3/3E3) was reported to enhance strain specific potencies up to 1400 folds higher than the mixture of the individual VHHs (PMID: 31544844).
- ApplicationsELISA, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID2E7 (L92E7)
- Gene ID155971
- Target nameenv
- Target descriptionEnvelope surface glycoprotein gp160, precursor
- Target synonymsEnvelope surface glycoprotein gp160, precursor; HIV1gp8
- HostRabbit
- IsotypeIgG
- Protein IDP04578
- Protein NameEnvelope glycoprotein gp160
- Scientific DescriptionThis chimeric rabbit antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.
- ReactivityVirus
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203